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Abstract For recommendations of speciﬁc targets for the
absolute amount of saturated fat intake, we need to know
what dietary intake is most appropriate? Changing agri-
cultural production and processing to lower the relative
quantities of macronutrients requires years to accomplish.
Changes can have unintended consequences on diets and
the health of subsets of the population. Hence, what are the
appropriate absolute amounts of saturated fat in our diets?
Is the scientiﬁc evidence consistent with an optimal intake
of zero? If not, is it also possible that a ﬁnite intake of
saturated fats is beneﬁcial to overall health, at least to a
subset of the population? Conclusive evidence from pro-
spective human trials is not available, hence other sources
of information must be considered. One approach is to
examine the evolution of lactation, and the composition of
milks that developed through millennia of natural selective
pressure and natural selection processes. Mammalian
milks, including human milk, contain 50% of their total
fatty acids as saturated fatty acids. The biochemical for-
mation of a single double bond converting a saturated to a
monounsaturated fatty acid is a pathway that exists in all
eukaryotic organisms and is active within the mammary
gland. In the face of selective pressure, mammary lipid
synthesis in all mammals continues to release a signiﬁcant
content of saturated fatty acids into milk. Is it possible that
evolution of the mammary gland reveals beneﬁts to satu-
rated fatty acids that current recommendations do not
consider?
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Introduction
Diet, Fatty Acids, and Lipoproteins
Lipids and their simplest structural elements, the fatty
acids, provide myriad functions at all levels of cellular life.
Nutritional scientists are still wrestling to develop a rudi-
mentary understanding of the roles that dietary lipids exert.
Lipids as simple fats are the most concentrated energy
source in the diet. Until recently, this fact alone made lipids
a valuable food component; however, a global epidemic of
caloric imbalance and obesity has undermined this one
aspect of lipid nutrition. Nonetheless, dietary lipids are
well recognized as providing the essential fatty acids and to
dissolve and aid in the absorption of fat-soluble vitamins.
Fats also produce a broad range of effects to whole body
metabolism when consumed in foods. These effects,
although not yet fully understood, are a complex conse-
quence of the absolute and relative fat content, the fatty
acid composition, the structure of other components in the
foods, the timing of consumption and individual variations
among those consuming them. Once ingested, lipids
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within cells and tissues beyond providing simple energy.
Fatty acids are required for membrane synthesis, modiﬁ-
cations of proteins and carbohydrates, construction of
various structural elements in cells and tissues, production
of signaling compounds and for oxidative fuel. The ability
of lipids to associate spontaneously into multi-molecular
structures of non-polar substituents provides a unique
domain structure to biology (vesicles, globules, lipopro-
teins). These structures solubilize a variety of non-polar
and poorly soluble cellular and extracellular constituents
and transport such molecules within and between cells and
tissues.
Given these various roles, why would saturated fats be
so poorly thought of nutritionally? In one sense, saturated
fats in the diet are unnecessary. All organisms, including
humans, are fully capable of synthesizing saturated fatty
acids. In the absence of sufﬁcient dietary fat, the body is
apparently capable of synthesizing all of the saturated fatty
acids that it needs from the ubiquitous precursor building
block acetate. This does not mean to infer that all saturated
fatty acids are biologically indistinguishable. In fact, cells
produce a remarkable diversity of saturated fatty acids
under particular conditions, and although not all of their
functions are known, they are clearly not simply inter-
changeable. Compositional analyses reveal remarkable
speciﬁcities for particular saturated fatty acids in different
lipid classes, cellular compartments and tissues [1]. Stubbs
and Smith [2] reviewed studies aimed at understanding the
requirement of membranes for speciﬁc fatty acid compo-
sitions. Interestingly, although composition is sensitive to
polyunsaturated fatty acids, the content of saturated fatty
acids in rat tissue membrane phospholipids is relatively
constant at *40% regardless of dietary fat source, indi-
cating a control mechanism at some level. The de novo
synthesis of saturated fatty acids is inhibited by feeding a
high-fat diet [3], and membrane fragility resulting from
feeding a low dietary saturated fatty acid diet is overcome
by feeding a diet rich in fat [4].
The complexity of structure and the diversity of func-
tions of fatty acids, both unsaturated and saturated, remain
poorly understood, and in only a few biological situations
have distinct actions of fatty acids been described. The
majority of research on fatty acids consumed in the diet has
focused principally on their role in lipoprotein metabolism.
Authors of a recent meta-analysis of prospective studies on
dairy food consumption and incident vascular disease and
Type 2 diabetes concluded that it is not possible to estimate
quantitative relationships with disease incidence with any
conﬁdence. The authors also point out that apart from the
effects of dairy foods on plasma lipids and on blood
pressure, very little is known about the biological mecha-
nisms underlying such relationships [5]. Even for
lipoprotein metabolism, for which literally billions of
dollars have been invested in research, little is actually
known. For example, only in 2005 was the basic mecha-
nistic link between saturated fatty acids and cholesterol
metabolism revealed [6]. This relationship between satu-
rated fat in the diet and cholesterol metabolism was one of
the most bafﬂing scientiﬁc challenges of the twentieth
century. How could such a ubiquitous, non-essential
component of diets and tissues—saturated fat—cause an
increase in the accumulation of cholesterol-rich LDL in
blood? As scientiﬁc research on cholesterol metabolism
proceeded through the twentieth century, the question
became even more perplexing. Brown and Goldstein [7]
won the Nobel prize for identifying the LDL receptor on
the liver as being what controlled the concentration of
serum cholesterol. What then regulates the expression of
the LDL receptor on the surface of liver cells? Cellular
cholesterol levels within the liver cell simultaneously
control cholesterol synthesis and uptake by regulating the
expression of the genes for the proteins that make choles-
terol in the cell and for the proteins that take up cholesterol
from blood as LDL. Not surprisingly, when cholesterol
levels in the cell are adequate, the genes are not turned on.
However, when cholesterol levels are low, all of these
genes are turned on using the identical transcription factor
protein—sterol response factor binding protein [8].
Although these studies made sense of cellular cholesterol
regulation—if the cell needs more cholesterol, it simulta-
neously turns on the genes to make more via cholesterol
biosynthetic enzymes and takes more from blood via the
LDL receptor—they failed to explain the role of diet in
these processes.
If the same transcription factor turns on both cholesterol
biosynthesis and the LDL receptor, how can saturated fat
uncouple these two processes, simultaneously making more
cholesterol and yet shutting down the receptor? Puigserver
and Spiegelman [9] found that the liver contains an addi-
tional gene control system, the peroxisome proliferator
activating receptor (PPAR), and it is in turn controlled by a
higher order protein complex termed (logically) the PPAR
gene transcription coactivator (PGC-1). This transcription
factor coactivator family recruits entire complexes of pro-
teins into transcriptional regulatory units controlling such
multi-faceted properties as mitochondrial biogenesis [10].
In a striking result, Lin et al. [6] discovered that, when
exposed to high levels of saturated fatty acids, liver cells
both in vivo and in vitro actively turned on PGC-1b, and
even more astonishingly, this coactivator simultaneously
turned on cholesterol biosynthesis and turned off the LDL
receptor. Thus, in one bold study, the basic target linking
dietary saturated fat and serum cholesterol was revealed.
This mechanism would account for the tendency of diets
very high in saturated fat to raise total cholesterol in blood.
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the risk factors for heart disease if they consumed diets high
in saturated fat. An obvious question is what are the beneﬁts
to this biochemical response that would have caused it to be
selected through evolution? Scientists are only now begin-
ning to address the basic biological value of this regulatory
control system. Nonetheless, diets very high in saturated fat
would not seem prudent, as would any diet high in any food
component.
Recommendations that the population decrease their
intake of saturated fats was based not on a mechanistic
understanding, but on years of observational evidence that
dietary saturated fats generally increase blood cholesterol
concentrations in animals and humans [11]. This alteration
of risk factors does not necessarily lead to increases in
heart disease and is certainly not universally true in all
populations studied. Some studies of human populations
evaluating the effects of saturated fat diets do not show the
predicted elevation in heart disease; in fact, some studies
see the reverse effect [12]. Recent studies are beginning
to assign genetic or physiological explanations to these
varying outcomes; for example, low birth weight appears to
have an effect on subsequent responses to dietary fat [13].
Beare-Rogers [14] suggested that the saturated fatty acid
requirements are also related to the stage of development.
For example, saturated fatty acids appear to be essential
for the newborn, the young and during rapid growth as
they are required for the synthesis of membranes and
lipoprotein.
Are Recommendations to Lower Total Fat Intakes
Justiﬁed for Everyone?
Is the justiﬁcation for broad recommendations to lower
total fat intakes in all individuals supported by scientiﬁc
evidence? In 1977, the US population was ﬁrst recom-
mended to reduce the intake of fat, with some recom-
mendations being to reduce total fat to below 30% of
calories [15]. The American Heart Association recom-
mended that the percentage of calories be 28.6 and 25.3%
total fat, respectively, and 9 and 6.1% saturated fat,
respectively, in Step 1 and Step 2 diets for treatment of
high blood cholesterol. This recommendation had unan-
ticipated effects. Framingham Heart Study data showed
that people with high triacylglycerol concentrations
([1.7 mmol/l) and low HDL cholesterol concentrations
(\1.03 mmol/l) run a signiﬁcantly higher risk of coronary
artery disease [16]. The long-term health beneﬁts of con-
suming a low-fat diet—particularly taking into account the
variation in human responses—have not been proven and,
to the contrary, some individuals move their risk proﬁle,
even for heart disease, in an adverse direction [17, 18]. In
one study, healthy, non-diabetic volunteers consumed diets
that contained, as a percentage of total calories, either 60%
carbohydrate, 25% fat and 15% protein, or 40% carbohy-
drate, 45% fat and 15% protein [19]. Those consuming the
60% carbohydrate diet had higher fasting plasma triacyl-
glycerol, remnant lipoprotein and remnant lipoprotein tri-
acylglycerol, and lower HDL cholesterol without changing
LDL cholesterol concentration. The low-fat diet lowered
HDL cholesterol and caused a persistent elevation in
remnant lipoproteins [19], both factors that are increasingly
recognized to be important independent risk factors for
heart disease and other metabolic diseases. These ﬁndings
led the investigators to publish the question whether it is
wise to recommend that all Americans replace dietary
saturated fat with carbohydrate. It is important to point out
that dietary carbohydrates have been associated with
dyslipidemia [20], and lipoprotein risk factors are similar
whether diets are high in fat and saturated fat or low in fat
and high in sugar. Elevated triglyceride concentrations are
related to increased hepatic secretion and impaired clear-
ance of VLDL lipoprotein [21, 22]. Triglyceride response
to dietary sugar may vary with the amount of sugar and the
presence of other nutrients. Stanhope and Havel [23]
reported that a high-fructose diet led to visceral adiposity,
dyslipidemia and insulin resistance, and insulin resistance
upregulates VLDL production. Perhaps the study most
devastating to the basic principle that a lower fat diet
improves the health of the entire population was a pro-
spective study (The Women’s Health Initiative Random-
ized Controlled Dietary Modiﬁcation Trial) that selected
approximately 49,000 women to compare a group of
women consuming low-fat diets and increased fruit and
vegetable consumption with a group receiving only diet-
related education materials. After 8.1 years, there were no
statistical differences in heart disease outcomes [24]. Two
possible interpretations could be drawn from this study:
ﬁrst, that lower fat intakes have no effect on any women,
and second, that individuals vary in their response to fat
and some women are beneﬁtted and some are adversely
affected and the net numbers of each are relatively close,
leading to a conclusion in this trial of no effect of a low-fat
diet.
Individual Response to Dietary Fat Intakes
Ordovas [25] reviewed key factors in lipid metabolism
and obesity that indicate an interplay among genes, gen-
der, and environmental factors that modulate disease
susceptibility. Studies of response to dietary fats have
found variation among individuals [26] and differences
between men and women [27] in their response to dietary
fat changes. Studies of individual sensitivity to changes in
dietary saturated fats showed groups of consistent hyper-
responders and minimal responders within a population of
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serum cholesterol in response to a decrease in dietary
saturated fat showed that total cholesterol decreased to a
greater extent in men than in women [27]. There are also
differential responses in individuals that consume low-fat
diets [28]. A series of studies showed that very-low-fat
(10%), high-carbohydrate diets enriched in simple sugars
increased the synthesis of fatty acids, especially palmitate,
and that the individual differences in increased blood
triglyceride concentrations varied considerably [29].
These ﬂuctuations observed time after time have given
impetus to the ﬁeld of Nutrigenomics, and scientists are
now pursuing more detailed analyses of individuals, their
responses to diet and the mechanistic basis for variations
in diet and health risk [30].
Controversy still remains high as to the roles that dietary
fat and cholesterol play in the risk of heart disease, and the
wealth of confounding factors demonstrate that saturated
fat is not an overwhelming input variable for any popula-
tion studied to date. Dietary saturated fats are not the only
variables associated with heart disease—the causes are
multi-factorial. The results of studies on the etiology of
heart disease are inclusive and sometimes contradictory. It
is time to take a broader view to the multiple actions and
functions of each of the different saturated fats and a more
individual view to assessment of diet and risk.
Biological Activities of Saturated Fatty Acids
The overwhelming emphasis on the role of saturated fats in
the diet and risk of coronary heart disease has distracted
investigators from studying other effects that individual
saturated fatty acids may have in the body. This omission is
perhaps important considering the abundance in mamma-
lian milks of a wide range of saturated fatty acids with
different chain lengths. In the context of evolution and the
obvious natural selective pressure on the development of
milk and all of its constituents, how do saturated fatty acids
affect growth, development and survival of mammalian
offspring?
Fatty acids are present in all body tissues, where they are
a major part of the phospholipid component of the cell
membrane. They contribute to the structural diversity
within the membrane, which is now recognized to be a key
aspect of membrane functions [31]. Fatty acids anchor
proteins to particular regions of cell membranes, partici-
pate in signaling activities, transport cellular components
and provide fuel. Saturated fatty acids have been suggested
as being the preferred fuel for the heart [32]. In the absence
of sufﬁcient fat from the diet, the body synthesizes fatty
acids, typically from carbohydrates. An interesting obser-
vation has been made that in adult rat liver, erucic acid
(22:1)—a fatty acid that has been associated with heart
disease and that is present in rapeseed oil—is rapidly
converted to 18:0, demonstrating the conservation of car-
bons by chain-shortening of a monounsaturated fatty acid
to an unsaturated fatty acid [33]. Even though all fatty
acids present in the diet can be broken down and resyn-
thesized into saturated fats, they have discrete effects.
Different structures of fatty acids appear to have differing
effects on a variety of metabolic and physiological pro-
cesses when they are ingested.
Short-chainfattyacidsarehydrolyzedpreferentiallyfrom
triacylglycerols and absorbed from the intestine into the
portal circulation without resynthesis of triacylglycerols.
These fatty acids serve as a ready source of energy. Butyric
acid (4:0) is the shortest saturated fatty acid and is present in
ruminant milk fat at 2–5% by weight [34], which on a molar
basis is about one-third the amount of palmitic acid (16:0).
Human milk contains a lower percentage (ca. 0.4%) of
butyric acid. No other common food fat contains this fatty
acid directly; however, the consumption of a wide range of
fermentable carbohydrates can lead to the synthesis of
butyricacidbyendogenousmicroﬂorainthelowerintestine.
Butyrate is a well-known modulator of genetic regulation,
and its ability to promote differentiation has led various
investigatorstopursuethismechanismasameanstoalterthe
risk and development of cancer [35, 36]. This fatty acid also
lowers processes of inﬂammation in the intestine, acting
through short-chain fatty acid-binding receptors [37].
In bovine and human milk, caproic acid (6:0) is present
at ca. 1 and 0.1%, respectively, and caprylic acid (8:0) and
capric acid (10:0) are present at ca. 0.3 and 1.2%, respec-
tively, of the milk fat. Not surprisingly from its nomen-
clature, goat milk contains the highest percentage of
caprylic acid, at 2.7% of milk fat. Studies to date have
documented that these three fatty acids have similar bio-
logical activities when tested as antimicrobial agents.
Caprylic acid lowers salmonella infection in chickens [38].
Caprylic and capric acid have antiviral activity. The
monoglyceride form, monocaprin, has been shown in vivo
in animals to possess antiviral activity against retrovirus
infection [39].
Lauric acid (12:0) is present in human and bovine milk
at ca. 5.8 and 2.2%, respectively, of the milk fat. Studies
have shown antiviral and antibacterial activities of lauric
acid [40, 41]. Release of lauric acid in the stomach may
have direct antimicrobial activities towards Helicobacter
pylori, either as the fatty acid or monoacylglycerols pro-
duced by lingual lipase(s) acting on the triacylglycerols
present milk fat [42, 43]. These antibacterial actions of
lauric acid have been proposed to provide anticaries and
antiplaque activities [44]. The overall antimicrobial effects
of the medium-chain saturated fatty acids and their mon-
oacylglycerol derivatives on various microorganisms,
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were originally suggested to be acting through the lipid
membranes of the organisms [45]. Support for this deac-
tivation process has been shown using human and bovine
milk [46]. Monolaurin released from milk lipids by lipases
may account for milk’s anti-protozoal activities [47]. The
biological activity of laurate has been interesting in other
aspects not related to the diet. For example, a remarkable
experiment showed that monolaurate provided consider-
able protection from HIV infection when used topically on
reproductive tissues in primates [48].
Bovine milk fat contains 8–14% myristic acid (14:0) and
in human milk, it averages 8.6% of the milk fat. Human
epidemiological studies have shown that myristic acid and
lauric acid were the saturated fatty acids most strongly
related to the average serum cholesterol concentrations in
humans [49]. Nonetheless, several studies have shown that
myristic acid increases HDL cholesterol at least as much as
LDL cholesterol, and further studies have demonstrated
that the unique positional distribution of myristic acid in
the sn-2 position of triglycerides in milk fat is responsible
for its tendency to raise HDL [50].
Palmitic acid is present in human and bovine milk at 22.6
and 26.3%, yet almost exclusively esteriﬁed at the sn-2
position of the triglyceride. This unusual stereospeciﬁc dis-
tribution appears to have important nutritional and biologi-
cal implications. Human infants consuming a formula
containing triacylglycerides similar to those in human milk
(16% palmitic acid esteriﬁed predominantly to the sn-2
position) have improved intestinal absorption not just of the
palmitic acid but calcium as well [51, 52]. Recently,
Speigelman’s group showed that palmitic acid stimulated
the expression and activities of the transcription coactivator
PGC-1b and by so doing promoted the transcriptional reg-
ulationofbiosynthesisoflipoproteinsfromtheliver[6].This
ﬁnding places a mechanistic understanding of the cellular
actions of saturated fatty acids, particularly palmitic acid. In
the context of milk, this mechanism implies that palmitic
acid may have an important role in promoting successful
lipoprotein metabolism in infants. This same transcription
coactivator PGC-1b was also found to promote myocardial
development [53]. Finally, PGC-1b was shown to increase
biogenesisofmitochondriainneurons[54],furtherimplying
that this mechanism could well be involved in diverse
aspects of metabolic regulation and its saturated fatty acid-
appropriate development throughout the body in infants.
Itisnotknownifthepresenceofpalmiticacidinhumanmilk
is important in the coordinate regulation and activity of
PGC-1b in any of these activities.
Stearic acid (18:0) is an abundant fatty acid in milk,
presentinhumanandbovinemilkfatat7.7and13.2%offat,
respectively. Stearic acid is synthesized from palmitate via
the elongase enzyme, either in the mammary gland by the
same enzyme that is active in liver, coded by gene ELOV5
[55, 56], or by ELOV1, whose expression is induced in the
mammary gland during lactation [57, 58]. Both of these
genes are regulated by diet, hence the net production of
stearic acid is under various aspects of metabolic control.
Surprisingly, little research has pursued the speciﬁc actions
of stearic acid when consumed in milk by infants, in spite of
its abundance and obvious regulation within the mammary
gland during fat synthesis. In adults, stearic acid does not
appear to raise serum cholesterol, hence it is considered
neutral to heart disease risk. This fatty acid may exert other
effects also consistent with protectionfrom heart disease via
separate mechanisms. Healthy males who consumed dietary
stearic acid (19 g/d) for 4 weeks exhibited beneﬁcial effects
on thrombogenic and atherogenic risk factors as compared
with the effects of dietary palmitic acid [59].
Delivery of Fat-Soluble Nutrients
Fat-soluble nutrients include the essential nutrients vitamins
A,D,EandK,carotenoidsasvitaminAprecursors,essential
polyunsaturated fatty acids, and non-essential nutrients such
as various tocopherols, phenolics, carotenoids (e.g., lyco-
pene, lutein and zeaxanthin) and conjugated linoleic acid
isomers that cannot be made by humans. Fat-soluble nutri-
ents are increasingly recognized as pleotrophic nutrients
with several discrete actions in addition to the direct func-
tions for which their essentiality has been established. As a
result, consumption of these components is considered to
have biological activities beyond the simple prevention of
deﬁciency and is consistent with many aspects of health
[60–62]. In epidemiological studies, the abundance of
fat-soluble nutrients in tissues is frequently reported to be
inversely correlated with a variety of chronic and degener-
ative diseases, including cancers [63, 64], cardiovascular
diseases [65, 66], diabetes [67] and speciﬁc tissue degener-
ation such as macular degeneration [68][ 58, 59]. With the
recognition that there are potential health values associated
with the presence of fat-soluble nutrients in tissues, their
absorption from the diet has become a key issue. In general,
non-polarmoleculesarepoorlyabsorbed,anditisnotcertain
that the presence of a component in a food means that it will
be absorbed and delivered to particular tissues in which it
might be active [69]. The lipid-soluble components of milk
appear to be well absorbed into and accumulated in tissues,
although the basic mechanisms by which such a net delivery
is accomplished are not known [70, 71].
Milkfat and HDL
Breast feeding stimulates the production of serum lipids
and lipoproteins [72, 73]. Interestingly, this increase in
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Nonetheless, throughout life, when compared with either
carbohydrates or polyunsaturated fatty acids, the con-
sumption of bovine milk fat results in the elevation of
circulating HDL cholesterol. Decades of research have
documented that blood HDL cholesterol concentrations are
a very strong and independent predictor of heart disease
[75]. This relationship has not been as successfully
exploited therapeutically as lowering LDL, however,
because HDL concentrations are not as responsive to diet
and drugs as those of LDL. A major pharmacologic effort
has pursued an increase in HDL cholesterol concentrations
in humans as a means to reduce cardiovascular risk. This
research is based on the extensive evidence of the associ-
ations of high HDL with protection from heart disease,
even in the face of elevated LDL. There is also evidence of
an opposite relationship, that low HDL is associated with
increased risk, with or without elevated triglycerides.
However, it has not been possible to assign independent
variables to HDL differences, and studies have largely been
based on HDL concentrations that are presumably high or
low based on genetic rather than dietary determinants
[76, 77].
HDL exert beneﬁcial effects on overall health by myriad
mechanisms, including binding and eliminating toxins,
delivering bioactive compounds, protecting various cells
and lipoproteins from damage and participating in their
repair [78–80]. HDL is particularly important in the suc-
cessful response to infection by binding and clearing bac-
terial endotoxin or lipopolysaccharide (LPS). LPS is the
major glycolipid component of gram-negative bacterial
outer membranes and is responsible for pathophysiological
symptoms characteristic of infection. A wide variety of
studies have documented that LPS is associated with
plasma lipoproteins, suggesting that sequestering of LPS
by lipid particles may form an integral part of a humoral
detoxiﬁcation mechanism [81, 82]. The binding of LPS to
lipoproteins is highly speciﬁc under simulated physiologi-
cal conditions, and HDL has the highest binding capacity
for LPS [83, 84]. This basic protection mechanism may be
particularly important for children [85] and for intestinally
derived endotoxin. Thus, lipoprotein-binding protein–
lipoprotein complexes may be part of a local defense
mechanism of the intestine against translocated bacterial
toxin. Because milk fats enhance HDL concentrations, they
are of potential importance in protection against bacterial
LPS toxicity.
Conclusions
The genes and biochemical processes of lactation that
produce milk fat evolved under the constant selective
pressure of nourishing mammalian infants. Lipids in milk
are a source of energy for the neonate of each species. The
composition and structures of lipids in milk provide bio-
active components that, although not identiﬁed as ‘‘essen-
tial’’ nutrients by standard deﬁnitions, none-the-less serve
important functions as structural building blocks, fuels,
transport systems, anti-inﬂammatory, anti-bacterial and
antiviral agents in the intestine. These lipids include tria-
cylglycerols—which are metabolized to monoacyl- and
diacylcerides and fatty acids—and phospholipids such as
sphingomyelin. The lipids in milk are also carriers of
important fat-soluble vitamins such as vitamin E, vitamin
A and vitamin D.
The absolute quantities and proportionate balance of the
various macronutrients in human diets remains the subject
of both scientiﬁc research and public health speculation.
Although unquestionably evolved to nourish infants,
detailed examinations of milk and lactation in humans and
other mammals are revealing new insights into structures
and functions of different components in the diet, including
fat. The gene set responsible for the production of lipids is
a conspicuously retained subset of the genome throughout
mammalian lactation, implying that milk is, in many
respects, a lipid delivery system [86]. Saturated fatty acids
are a signiﬁcant component of all mammalian milks
examined, including human milk. Thus, whereas diets
inordinately high in any component are likely to be net
deleterious, ﬁnite quantities of saturated fatty acids may
provide distinct mechanistic beneﬁts to various metabolic
processes. Recognizing that different humans with differ-
ent lifestyles respond differently to fat intakes and com-
positions implies that in the future, diets will be designed
for individuals not populations. In such a future, ﬁnite
intakes of speciﬁc saturated fats may actually be
recommended.
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